ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/17/2020
Closing price: 62.98
Support price level: N/A
Resistance price level: $64.12
Relative strength index (14-day RSI) 25.9
Beta 0.93
  • GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • With a -8.3 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • GILD is one of this month's worst performers with a return of -4.1%, underperforming 90 percent of stocks in the S&P-100.

  • Down 3.2 percent, GILD is one of this week's biggest decliners.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$61.62 $70.05 17.0%
200 day 50 day 20 day 10 day
$65.37 $65.59 $65.22 $64.62
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
26.5% 23.7% 23.7% 26.7%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 6.4% in the next week.

  • 15.1% in the next month.

  • 45.5% in the next year.